Contrive Datum Insights has published "Medical Equipment Financing Market Size, Share & Industry Analysis, By Equipment (Diagnostics Equipment, Therapeutic Equipment, Patient Monitoring Equipment, Laboratory Equipment, Medical Furniture), Type (New Medical Equipment, Rental Equipment, Refurbished Equipment), End user (Hospitals, Clinics Dermatology Clinics, Dental Clinics, Ophthalmology Clinics, Laboratories & Diagnostic Centers, Ambulatory Surgical Centers, Others), Financing type (Loans, Leases, Lines of Credit / Working Capital), Provider type (Banks, Non-Banking Financial Companies (NBFCs), OEM Captive Finance Units, Independent Leasing Companies), and Regional Forecast, 2026-2034". The study sizes the global medical equipment financing market at USD 195 billion in 2025 and projects growth from USD 209 billion in 2026 to USD 401.44 billion by 2034, a compound annual growth rate of 8.5% across the forecast period.
Medical equipment financing covers the loans, leases and lines of credit that healthcare providers use to acquire diagnostic, therapeutic, patient monitoring, laboratory and furniture equipment without paying the full purchase price upfront. It spans new equipment purchases as well as rental and refurbished arrangements, structured as term loans, operating or finance leases, or working capital facilities tied to a specific asset. Buyers range from large hospital systems to independent clinics, diagnostic laboratories and ambulatory surgical centers that need predictable payment schedules to fund capital-intensive equipment.
Provider preference for financing over capital purchase
Provider preference for financing over capital purchase is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 8.5% a year, the equipment lines exposed to it move fastest: Patient Monitoring Equipment compounds at 9.65%, taking its share of revenue from 20% to 22% and its value from USD 39 billion to USD 88.32 billion.
Where the forecast could be beaten: bull case assumes outpatient and ambulatory care capacity expands faster than the base case, and that NBFC and OEM captive lenders extend financing to more smaller clinics than the base case assumes. The study puts that case at USD 441.58 billion in 2034, against USD 401.44 billion in the base.
Against that, bear case assumes interest rates stay elevated for longer, tightening underwriting standards further and slowing hospital financing approvals relative to the base case. On that reading 2034 revenue stops at USD 361.3 billion. The weight of the problem sits in Diagnostics Equipment: 32% of 2025 revenue growing at 7.73%, well under the market's 8.5%.
Diagnostics Equipment Scale Against Patient Monitoring Equipment Momentum
Suppliers here are separated by equipment, not by geography. The incumbent position is Diagnostics Equipment: 32% of 2025 revenue, USD 62.4 billion, and still 30% in 2034. The contested position is Patient Monitoring Equipment at 9.65% growth. Few suppliers hold both, which is why a market of USD 195 billion supports as many participants as it does.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Type | New Medical Equipment | 55% · USD 107.25 billion | Refurbished Equipment 12.48% |
| End user | Hospitals | 42% · USD 81.9 billion | Ambulatory Surgical Centers 10.57% |
| Financing type | Loans | 45% · USD 87.75 billion | Leases 9.51% |
| Provider type | Banks | 38% · USD 74.1 billion | OEM Captive Finance Units 9.51% |
- Regionally, the lead sits with North America: 38% of 2025 global revenue, USD 74.1 billion rising to USD 140.5 billion in 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 27% in 2025 to 32% in 2034, with revenue growing from USD 52.65 billion to USD 128.46 billion.
- Middle East and Africa remains the smallest region throughout, at 5% of 2025 revenue and 5% by 2034.
- By equipment, the largest line in 2025 was Diagnostics Equipment, at 32% of revenue and USD 62.4 billion.
- No equipment line grows faster than Patient Monitoring Equipment, at a projected 9.65%.
- The United States is the largest single country market at USD 62.99 billion in 2025, 32.3% of global revenue.
The study covers five axes, by equipment, and by type, end user, financing type and provider type, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 361.3 billion and USD 441.58 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.